Clinical Trials: Rethinking How We Ensure Quality
Description
This article is the version submitted to the publisher which was accepted without
revision.
Type
Journal articlePermalink
https://hdl.handle.net/10161/6095Published Version (Please cite this version)
10.1177/0092861512464372Publication Info
(2012). Clinical Trials: Rethinking How We Ensure Quality. Drug Information Journal, 46(6). pp. 657-660. 10.1177/0092861512464372. Retrieved from https://hdl.handle.net/10161/6095.This is constructed from limited available data and may be imprecise. To cite this
article, please review & use the official citation provided by the journal.
Collections
More Info
Show full item recordScholars@Duke
Judith Mae Kramer
Professor Emeritus of Medicine
· Studying methods to facilitate the uptake of evidence-based treatment recommendations.
· Optimizing the use of drugs, devices, and biological products in clinical practice.
· Studying methods of risk management for therapeutic products
Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info